α1‐Adrenoceptor antagonists prevent paracetamol‐induced hepatotoxicity in mice
- 1 February 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 153 (4) , 820-830
- https://doi.org/10.1038/sj.bjp.0707620
Abstract
Background and purpose: Paracetamol, a major cause of acute liver failure (ALF) represents a significant clinical problem. Adrenoceptor stimulation or antagonism can modulate chemical‐induced hepatotoxicity. We investigated the role of endogenous catecholamines and α1‐adrenoceptors in the development of paracetamol‐ induced hepatotoxicity.Experimental approach: Paracetamol (3.5 mmol kg−1) was administered to male CD‐1 mice, with and without α1‐adrenoceptor antagonists (prazosin, doxazosin, terazosin and tamsulosin; 35.7 μmol kg−1). Serum transaminases and hepatic glutathione (GSH) levels were assessed as markers of hepatic damage. Paracetamol bioactivation was assessed by covalent binding, hepatic and urinary conjugate formation and uridine glucuronosyltransferase activity. Plasma catecholamines levels and hepatic congestion were also analysed.Key results: Plasma catecholamine levels were significantly elevated 5 h post paracetamol administration. Prazosin prevented hepatotoxicity when administered 1 h before a toxic paracetamol insult and importantly, when administered up to 1 h post paracetamol injection. Prazosin had no effect on paracetamol‐induced depletion of hepatic GSH, paracetamol bioactivation or paracetamol‐induced transcription of defence genes. Paracetamol toxicity is associated with marked accumulation of erythrocytes within hepatic sinusoids and prazosin completely prevented this accumulation.Conclusion and implications: Paracetamol‐induced hepatocellular damage is associated with increased circulating catecholamines. α1‐Adrenoceptor antagonists conferred complete protection from paracetamol ‐induced hepatotoxicity. Protection was associated with absence of hepatic erythrocyte accumulation. Increased catecholamine levels may contribute to the pathophysiology of paracetamol‐induced hepatotoxicity by compromising hepatic perfusion. Protection against paracetamol toxicity by α1antagonists in mice has implications for therapeutic management of patients presenting with paracetamol overdose and ALF.British Journal of Pharmacology(2008)153, 820–830; doi:10.1038/sj.bjp.0707620; published online 10 December 2007Keywords
This publication has 55 references indexed in Scilit:
- Protection against paracetamol-induced hepatic injury by prazosin pre-treatment in CD-1 miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Hepatocellular response to chemical stress in CD-1 mice: Induction of early genes and γ-glutamylcysteine synthetaseHepatology, 2000
- The assay of the catecholamine content of small volumes of human plasmaBiomedical Chromatography, 1999
- Metabolism of tamsulosin in rat and dogXenobiotica, 1996
- α1-Adrenoceptor subtype selectivity of tamsulosin: Studies using livers from different speciesEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Phenylpropanolamine Potentiation of Acetaminophen-Induced Hepatotoxicity: Evidence for a Glutathione-Dependent MechanismToxicology and Applied Pharmacology, 1993
- Antagonism of bromobenzene-induced hepatotoxicity by the α-adrenoreceptor blocking agents phentolamine and idazoxan: Role of hypothermiaToxicology and Applied Pharmacology, 1989
- Antagonism of bromobenzene-induced hepatotoxicity by the α-adrenergic blocking agents, phentolamine and idazoxanToxicology and Applied Pharmacology, 1988
- Effects of ventromedial and lateral hypothalamic stimulation on chemically-induced liver injury in ratsLife Sciences, 1988
- Catecholamine potentiation of carbon tetrachloride-induced hepatotoxicity in miceToxicology and Applied Pharmacology, 1969